On the other hand, plasma FGF21 levels were associated with adverse lipid profiles including HDL-c, LDL-c and triglyceride (all P<0.05) after adjustment for age, gender, BMI and diabetes mellitus in all CKD subjects. This evidence concerns the gene FGF21 and chronic kidney disease.